Search research articles
Contact Us
Filters
Showing results (311-320 of 467) with videos related to
Page
of 47
Sort By:
Journal of Nephrology
|
March 3, 2021
Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection
Chiara Lanzani, Marco Simonini, Teresa Arcidiacono, et al.
The Journal of Antimicrobial Chemotherapy
|
July 22, 2025
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era
Rebecka Papaioannu Borjesson, Sara Diotallevi, Riccardo Lolatto, et al.
Surgery
|
August 8, 2025
Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy
Domenico Tamburrino, Giovanni Guarneri, Lorenzo Provinciali, et al.
Plos One
|
February 14, 2017
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients
Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, et al.
The Journal of Antimicrobial Chemotherapy
|
April 22, 2023
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study
Ili Margalit, Giusy Tiseo, Marco Ripa, et al.
International Journal of Antimicrobial Agents
|
January 28, 2023
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry
Francesco Saladini, Federica Giammarino, Franco Maggiolo, et al.
Microbiology Spectrum
|
September 11, 2025
Teropavimab and zinlirvimab sensitivity in people living with multidrug-resistant HIV-1: data from the PRESTIGIO Registry
Vincenzo Spagnuolo, Laura Galli, Jiani Li, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
November 6, 2025
Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: Preliminary observations from the PRESTIGIO registry
Tommaso Clemente, Mehdi Benlarbi, Rebecka Papaioannu Borjesson, et al.
Antioxidants (Basel, Switzerland)
|
May 25, 2024
Assessment of the Antioxidant and Hypolipidemic Properties of <i>Salicornia europaea</i> for the Prevention of TAFLD in Rats
Aymen Souid, Lucia Giambastiani, Antonella Castagna, et al.
Journal of Medical Virology
|
January 26, 2011
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy
Nicola Gianotti, Laura Galli, Maurizio Zazzi, et al.
Page
of 47
Search research articles
Search
Showing results (311-320 of 467) with videos related to
Sort By:
Page
of 47
Journal of Nephrology
|
March 3, 2021
Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection
Chiara Lanzani, Marco Simonini, Teresa Arcidiacono, et al.
The Journal of Antimicrobial Chemotherapy
|
July 22, 2025
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era
Rebecka Papaioannu Borjesson, Sara Diotallevi, Riccardo Lolatto, et al.
Surgery
|
August 8, 2025
Multidrug-resistant bacterial colonization affects postoperative outcomes after pancreaticoduodenectomy
Domenico Tamburrino, Giovanni Guarneri, Lorenzo Provinciali, et al.
Plos One
|
February 14, 2017
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients
Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, et al.
The Journal of Antimicrobial Chemotherapy
|
April 22, 2023
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study
Ili Margalit, Giusy Tiseo, Marco Ripa, et al.
International Journal of Antimicrobial Agents
|
January 28, 2023
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry
Francesco Saladini, Federica Giammarino, Franco Maggiolo, et al.
Microbiology Spectrum
|
September 11, 2025
Teropavimab and zinlirvimab sensitivity in people living with multidrug-resistant HIV-1: data from the PRESTIGIO Registry
Vincenzo Spagnuolo, Laura Galli, Jiani Li, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
November 6, 2025
Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: Preliminary observations from the PRESTIGIO registry
Tommaso Clemente, Mehdi Benlarbi, Rebecka Papaioannu Borjesson, et al.
Antioxidants (Basel, Switzerland)
|
May 25, 2024
Assessment of the Antioxidant and Hypolipidemic Properties of <i>Salicornia europaea</i> for the Prevention of TAFLD in Rats
Aymen Souid, Lucia Giambastiani, Antonella Castagna, et al.
Journal of Medical Virology
|
January 26, 2011
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy
Nicola Gianotti, Laura Galli, Maurizio Zazzi, et al.
Page
of 47